Strong innovation and M&A activity support a bullish outlook for the biotech ETF through 2026.
Globant Expands Glob.AI OS To Turn Enterprise AI Adoption Into Measurable Business Results
Globant launched Glob.AI OS, a governance platform to manage enterprise AI models and track costs.